FDA Approved: SPIRONOLACTONE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approved a supplemental application for spironolactone from Padagis US LLC, indicating an updated regulatory action on this product (supplemental filing).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)